| Clinical Trials |
| Results 61 - 70 of about 80 for Psychiatry. Search took 0.04 seconds. |
An Exploratory Phase II Study to Determine the Safety and Tolerability and activity of a Novel Vasopressin 1a Receptor Antagonist
in Adults with DSM-5 Intermittent Explosive Disorder (IED)
Principal Investigator(s): Antonia S New
An Exploratory Phase II Study to Determine the Safety and Tolerability and activity of a Novel Vasopressin 1a Receptor Antagonist
in Adults with DSM-5 Intermittent Explosive Disorder (IED)
Principal Investigator(s): Antonia S New
A Randomized, Placebo Controlled, Parallel-Group, Double Blind Efficacy and Safety Trial of MK-8931 in Subjects with Mild
to Moderate Alzheimer's Disease (EPOCH)
Principal Investigator(s): Judith A Neugroschl
The TOMMORROW Study: A Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Simultaneously Qualify a Biomarker
Algorithm for Prognosis of Risk of Developing Mild Cognitive Impairment due to Alzheimer's Disease (MCI due to AD) and to
Test the Safety and Efficacy of Pioglitazone (AD-4833 SR 0.8 mg QD) to Delay the Onset of MCI due to AD in Cognitively Normal
Subjects
Principal Investigator(s): Judith A Neugroschl
Cognitive processes related to anxious and compulsive traits
Principal Investigator(s): Emily Stern
Effects of ondansetron in obsessive-compulsive and tic disorders
Principal Investigator(s): Emily Stern
Neurobiology of sensory phenomena in obsessive-compulsive disorder
Principal Investigator(s): Emily Stern
Behavioral and fMRI studies of cognition in healthy individuals and patients with anxiety
Principal Investigator(s): Emily Stern
Behavioral and fMRI studies of cognition in healthy individuals and patients with anxiety
Principal Investigator(s): Emily Stern
Autistic endophenotypes and their associations to oxytocin and cholesterol
Principal Investigator(s): Jeremy M Silverman
Powered by Google Search Appliance